Low dose Aspirin and high-risk pregnancy: Evaluation of the effect of acetylsalicylic acid on the inhibition of platelet aggregation

2017 ◽  
Vol 77 (04) ◽  
pp. 379-395
Author(s):  
C Stern ◽  
K Mayer-Pickel ◽  
EC Weiss ◽  
U Lang ◽  
M Cervar-Zivkovic ◽  
...  
2021 ◽  
Vol 9 (1) ◽  
pp. 3286-3290
Author(s):  
Oktaviany Irma Wiputri ◽  
◽  
Yulistiani Yulistiani ◽  
Eddy Z Monsir ◽  
Dewi Ramdani ◽  
...  

1997 ◽  
Vol 16 (2) ◽  
pp. 229-238 ◽  
Author(s):  
Eileen D.M. Gallery ◽  
Margaret R. Ross ◽  
Margaret Hawkins ◽  
Garth Leslie ◽  
Ákos Z. Györy

2013 ◽  
Vol 77 (12) ◽  
pp. 3023-3028 ◽  
Author(s):  
Sadanori Okada ◽  
Takeshi Morimoto ◽  
Hisao Ogawa ◽  
Mio Sakuma ◽  
Hirofumi Soejima ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Dagmar Wertaschnigg ◽  
Maya Reddy ◽  
Ben W. J. Mol ◽  
Fabricio da Silva Costa ◽  
Daniel L. Rolnik

In this review, we discuss the recent literature regarding the prevention of preeclampsia and aim to answer common questions that arise in the routine antenatal care of pregnant women. Prescription of low-dose aspirin for high-risk patients has been shown to reduce the risk of preeclampsia (PE). A daily dose between 100 and 150 mg taken in the evening should be initiated prior to 16 weeks of gestation and can be continued until delivery. Calcium supplementation seems to be advantageous but currently it is only considered for patients with poor dietary intake and high risk for PE. Recent data about heparin are still conflicting, and therefore, heparin can currently not be recommended in the prevention of PE.


Sign in / Sign up

Export Citation Format

Share Document